From a risk perspective MVM would allow for future expansion and diversity of manufacture. Not opposed to the purchase of Synlait, but not for any price.
- Forums
- ASX - By Stock
- A2M
- Media Updates
Media Updates, page-14058
-
- There are more pages in this discussion • 348 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.98 |
Change
0.110(1.60%) |
Mkt cap ! $5.060B |
Open | High | Low | Value | Volume |
$6.89 | $7.00 | $6.86 | $3.025M | 434.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 8459 | $6.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.98 | 4947 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 7439 | 6.970 |
11 | 15301 | 6.960 |
16 | 17577 | 6.950 |
8 | 7458 | 6.940 |
12 | 34510 | 6.930 |
Price($) | Vol. | No. |
---|---|---|
6.980 | 6745 | 6 |
6.990 | 27147 | 14 |
7.000 | 48955 | 27 |
7.010 | 30141 | 13 |
7.020 | 9748 | 8 |
Last trade - 11.09am 13/06/2024 (20 minute delay) ? |
|
|||||
Last
$6.99 |
  |
Change
0.110 ( 2.18 %) |
|||
Open | High | Low | Volume | ||
$6.87 | $7.00 | $6.86 | 178142 | ||
Last updated 11.30am 13/06/2024 ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online